CXCL12/CXCR4 pathway is activated by oncogenic JAK2 in a PI3K-dependent manner

JAK2 activation is the driver mechanism in BCR-ABL-negative myeloproliferative neoplasms (MPN). These diseases are characterized by an abnormal retention of hematopoietic stem cells within the bone marrow microenvironment and their increased trafficking to extramedullary sites. The CXCL12/CXCR4 axis...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelouahab, Hadjer, Zhang, Yanyan, Wittner, Monika, Oishi, Shinya, Fujii, Nobutaka, Besancenot, Rodolphe, Plo, Isabelle, Ribrag, Vincent, Solary, Eric, Vainchenker, William, Barosi, Giovanni, Louache, Fawzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589564/
https://www.ncbi.nlm.nih.gov/pubmed/28903325
http://dx.doi.org/10.18632/oncotarget.10789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589564/
https://www.ncbi.nlm.nih.gov/pubmed/28903325
http://dx.doi.org/10.18632/oncotarget.10789

Ejemplares similares